You are here:
What we Do
The purpose of the Scottish Medicines Consortium (SMC) is to accept for use those newly licensed drugs that clearly represent good value for money to NHSScotland. SMC analyses information supplied by the drug manufacturer on the health benefits of the drug and justification of its price. As the NHS has limited resources, SMC works to make sure that those drugs which represent good value for money are accepted for routine use as quickly as possible so that they can benefit patients. The Consortium is made up of lead clinicians, pharmacists and health economists together with representatives of health boards, the pharmaceutical industry and the public.
